Kraig Biocraft Laboratories Inc (KBLB)

[beacham]

In mid 2019, the SP reached $0.45, or so. Primarily, it happened on the prospect of uplisting to a better exchange, presumably NASDAQ. It is worthwhile to review the PRs of 2019 especially the responses CEO Thompson gave to two shareholders named Gary and Zach. The ‘small window’ of opportunity came and went, w/o uplisting. The SP responded accordingly. How time flies.

Aug 2019 is also when this happened - https://www.kraiglabs.com/kraig-biocraft-laboratories-completes-construction-of-spider-silk-biotech-research-laboratory-in-vietnam/. “… eleven separate labs …”. Worth a re-read. In April of 2020 the following PR occurred. It prompted a brief surge to about $0.30. Then the hysteria and mania of the Covid nonsense burst upon the scene and we, along w/ everybody else, were bamboozled to run for cover. The SP continued w/ the downward trajectory bottoming out at $0.03 in Dec. 2023.

https://www.kraiglabs.com/kraig-biocraft-laboratories-achieves-knock-in-knock-out-success-to-create-nearly-pure-spider-silk/

<<<<< ANN ARBOR, Mich., April 16, 2020 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk based fibers, announced, at a press conference held after today’s market close, that it successfully developed a new technology platform, based on a non-CRISPR gene editing knock-in knock-out technology. Other than the silkworm’s remaining specifically desired native silk protein elements, the Company is now able to produce nearly pure spider silk.

The new technology has a purity rate that is about ten times greater than Dragon Silk, a fiber that the Company developed with its previous tools. Dragon Silk has already demonstrated to be tougher than many fibers used in bullet proof vests and the Company expects that the increased spider silk purity, created using this new approach, will yield materials beyond those capabilities.

This new system utilizes the Company’s eco-friendly and cost effective silkworm production system, which is significantly more advanced than any of the competing methods.

Press Conference highlights include:
* Generation II Spider Silk Technology- Essentially pure spider silk.
* Generation III Spider Silk Technology- More specific customization.
* The Company’s knock-in knock-out technology allows Kraig Labs to work with very complex protein sequences in silkworm, which are about four times more complex than published technologies.
* Dr. Trevor Kane, the Company’s Chief Scientific Officer, stated that his team is already working on producing even larger, more complex, constructs, based on the Darwin’s bark spider.  
* Ambitious immunity boosting program will benefit not only the Company’s proprietary transgenics, but will help strengthen production for the mundane silk market, which is a $5 billion a year industry.
* The New Technology, which is the result of over ten years of effort, hits the target of one of the Company’s primary technological goals and opens the door for large scale US production.

This new technology has applications and implications far beyond material performance. The Company is now well underway, and rapidly advancing, its efforts to enhance its silkworm technology to allow for large scale US production. The Company has already begun the validation process for the first of these new transgenics and anticipates US production to be possible as early as 2022 or 2023. >>>>>

In 2019, we surged to $0.45 on the expectation and anticipation of moving to the NASDAQ. The technology was pretty snazzy back then, for sure. The share price languished for 4 years but the company never stopped the research & development. Now take a look at the PRs from the mid Dec 2023 to the present day, 06 May 2024. The technology is significantly more advanced and our manufacturing capacity and ability is also far greater. Yet we still trade at $0.12, a far cry from the heady days of $0.45.

We are grossly undervalued by a factor of at least 3 times. MMs do what they do to line their pockets and companies on the OTC are helpless to stop them. The SP suffers as a result. There is no overt talk of an uplist but CEO Thompson knows all-too-well what is happening. Hopefully, you read the responses to the shareholders Gary and Zach. He, our CEO, makes it very clear his opinion of the OTC. Today, ‘uplist’ is looming large in the background but no talk of it out in the open. Not this time.

In the interim years, from 2019 til now, research and development went ahead at a feverish pace. We see the results reported in PRs from Dec 2023 to May 2024. The most recent PR dated 06 May 24 is an updated, snappier version of the one listed above. All systems are a GO and this time there is precious little to stand in our way. Like the big guy said, “We are in an entirely new ball game now”.

Seriously, again ? … BUY MORE SHARES !!!

We are the NEXT BIG THING. FULL. STOP.

Later, WBeacham